Increased Circulating Angiopoietin-Like Protein 8 Levels Are Associated with Thoracic Aortic Dissection and Higher Inflammatory Conditions.


Journal

Cardiovascular drugs and therapy
ISSN: 1573-7241
Titre abrégé: Cardiovasc Drugs Ther
Pays: United States
ID NLM: 8712220

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 9 2 2020
medline: 21 10 2020
entrez: 9 2 2020
Statut: ppublish

Résumé

Thoracic aortic dissection (TAD) is characterized by an inflammatory response. Angiopoietin-like protein 8 (ANGPTL8) is a hormone involved in the regulation of lipid metabolism and inflammation. However, the relationship between ANGPTL8 and TAD remains unknown. This case-control study included 78 TAD patients and 72 controls. The aortic diameter was evaluated by computed tomography and used to assess TAD severity. Circulating ANGPTL8 levels were measured by enzyme-linked immunosorbent assay. Associations of ANGPTL8 with TAD were determined by multivariate logistic regression. Serum ANGPTL8 levels were significantly higher in TAD patients compared with controls (562.50 ± 20.84 vs. 419.70 ± 22.65 pg/mL, respectively; P < 0.001). After adjusting for confounding factors, circulating ANGPTL8 levels were an independent risk factor for TAD (odds ratio = 1.587/100 pg ANGPTL8, 95% confidence interval [CI] = 1.121-2.247, P < 0.001) and positively associated with diameter (β = 1.081/100 pg ANGPTL8, 95% CI = 0.075-2.086, P = 0.035) and high-sensitivity C-reactive protein (hs-CRP) (β = 0.845/100 pg ANGPTL8, 95% CI = 0.020-1.480, P = 0.009). The area under the curve (AUC) on receiver operating characteristic (ROC) analysis of the combination of ANGPTL8, hs-CRP, and D-dimer was 0.927, and the specificity and sensitivity were 98.46% and 79.49%, respectively. ANGPTL8 was significantly increased in TAD tissue compared with controls. In vitro, ANGPTL8 was increased in angiotensin II (AngII)-treated macrophages and vascular smooth muscle cells (VSMCs), while ANGPTL8 siRNA-mediated knockdown decreased inflammatory factors in AngII-treated macrophages and decreased apoptosis in AngII-treated VSMCs. ANGPTL8 is associated with TAD occurrence and development, which may involve pro-inflammatory effects on macrophages. ANGPTL8 combined with D-dimer and hs-CRP might be a useful clinical predictor of TAD. ChiCTR-COC-17010792 http://www.chictr.org.cn/showproj.aspx?proj=18288.

Identifiants

pubmed: 32034642
doi: 10.1007/s10557-019-06924-7
pii: 10.1007/s10557-019-06924-7
pmc: PMC7093348
doi:

Substances chimiques

ANGPTL8 protein, human 0
Angiopoietin-Like Protein 8 0
Angiopoietin-like Proteins 0
Biomarkers 0
Cytokines 0
Fibrin Fibrinogen Degradation Products 0
Inflammation Mediators 0
Peptide Hormones 0
fibrin fragment D 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-77

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Aorta (Stamford). 2013 Dec 01;1(6):259-67
pubmed: 26798703
Clin Biochem. 2013 Aug;46(12):1026-1029
pubmed: 23742758
Chest. 2000 May;117(5):1271-8
pubmed: 10807810
Circulation. 2015 Sep 29;132(13):1224-33
pubmed: 26330412
Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1400-9
pubmed: 22556334
Circulation. 2018 Jan 16;137(3):259-269
pubmed: 29146682
BMC Cardiovasc Disord. 2017 Jul 27;17(1):206
pubmed: 28750662
Crit Care. 2013 Feb 25;17(1):R33
pubmed: 23442769
Open Biol. 2016 Apr;6(4):150272
pubmed: 27053679
Neural Plast. 2017;2017:3256325
pubmed: 29098089
Int Heart J. 2019 Jul 27;60(4):919-923
pubmed: 31257330
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):458-463
pubmed: 30641744
Eur J Vasc Endovasc Surg. 2017 Mar;53(3):337-345
pubmed: 27889204
Br J Pharmacol. 2017 Oct;174(20):3466-3481
pubmed: 28147449
J Cardiothorac Surg. 2015 Jan 16;10:3
pubmed: 25592634
Surg Obes Relat Dis. 2016 Aug;12(7):1343-1348
pubmed: 27178609
Lipids Health Dis. 2018 Jul 18;17(1):161
pubmed: 30021605
AJR Am J Roentgenol. 2001 Jul;177(1):207-11
pubmed: 11418429
Ann Med. 2014 Feb;46(1):44-8
pubmed: 24432723
Circ J. 2006 Dec;70(12):1598-601
pubmed: 17127806
Rev Bras Cir Cardiovasc. 2008 Oct-Dec;23(4):512-8
pubmed: 19229423
J Pathol. 2015 Jul;236(3):373-83
pubmed: 25788370
Sci Rep. 2016 Sep 23;6:31414
pubmed: 27659201
Heart Vessels. 2013 May;28(3):330-5
pubmed: 22570140
Circ Res. 2019 Feb 15;124(4):631-646
pubmed: 30763216
Hypertension. 2010 Feb;55(2):422-9
pubmed: 20038755
Ann Med. 2010 Dec;42(8):622-9
pubmed: 20860543
ANZ J Surg. 2007 May;77(5):329-32
pubmed: 17497968
Thromb Haemost. 2005 Nov;94(5):1094-8
pubmed: 16363254
Acta Pharmacol Sin. 2010 Oct;31(10):1376-80
pubmed: 20871623
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Cardiovasc Ther. 2012 Dec;30(6):308-16
pubmed: 22978789
Eur Heart J. 2003 Nov;24(22):2038-45
pubmed: 14613740
Aging (Albany NY). 2018 Nov 16;10(11):3627
pubmed: 30510150
Medicine (Baltimore). 2016 Oct;95(42):e5175
pubmed: 27759651
Ann Med. 2015;47(6):441-6
pubmed: 26339779
Front Endocrinol (Lausanne). 2018 Apr 17;9:169
pubmed: 29719529
BMJ Open. 2017 Oct 6;7(10):e015112
pubmed: 28988163
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3368-3373
pubmed: 31387395
Heart. 2013 Aug;99(16):1192-7
pubmed: 23813850
Circulation. 2011 May 24;123(20):2213-8
pubmed: 21555704
Ann Intern Med. 2018 Mar 6;168(5):351-358
pubmed: 29357392
Curr Opin Lipidol. 2019 Jun;30(3):205-211
pubmed: 30893111
Eur Heart J. 2014 Nov 1;35(41):2873-926
pubmed: 25173340
PLoS One. 2016 Nov 18;11(11):e0166285
pubmed: 27861531
J Cell Mol Med. 2019 Aug;23(8):5737-5750
pubmed: 31211513
Cell Stress. 2018 Feb 14;2(3):66-68
pubmed: 31225468
Front Endocrinol (Lausanne). 2014 Jan 23;5:4
pubmed: 24478758
Lipids Health Dis. 2018 Mar 1;17(1):35
pubmed: 29490644

Auteurs

Yunyun Yang (Y)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Key Laboratory of Upper Airway Dysfunction-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.

Xiaolu Jiao (X)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Key Laboratory of Upper Airway Dysfunction-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.

Linyi Li (L)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Key Laboratory of Upper Airway Dysfunction-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.

Chaowei Hu (C)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Key Laboratory of Upper Airway Dysfunction-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.

Xiaoping Zhang (X)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Key Laboratory of Upper Airway Dysfunction-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.

Lili Pan (L)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.

Huahui Yu (H)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Key Laboratory of Upper Airway Dysfunction-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.

Juan Li (J)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Key Laboratory of Upper Airway Dysfunction-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China.

Dong Chen (D)

Department of Pathology, Beijing An Zhen Hospital, Capital Medical University, Beijing, 100029, China.

Jie Du (J)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.

Yanwen Qin (Y)

Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China. qinyanwen@ccmu.edu.cn.
Key Laboratory of Upper Airway Dysfunction-related Cardiovascular Diseases, Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing, 100029, China. qinyanwen@ccmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH